Selected research
Industry Research
Pharmacokinetic Testing Industry Research Report 2026
Market perspective
The global Pharmacokinetic Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pharmacokinetic Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pharmacokinetic Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pharmacokinetic Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pharmacokinetic Testing include Certara, L.P., Evotec AG, Pacific BioLabs, GVK Biosciences Private Limited, SGS SA, LGC Limited, Pharmaceutical Product Development, LLC, Charles River Laboratories International, Inc. and Creative Bioarray. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pharmacokinetic Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pharmacokinetic Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharmacokinetic Testing Market by Company
Certara, L.P.
Evotec AG
Pacific BioLabs
GVK Biosciences Private Limited
SGS SA
LGC Limited
Pharmaceutical Product Development, LLC
Charles River Laboratories International, Inc.
Creative Bioarray
Pharmacokinetic Testing Segment by Type
Oral Dissolution Testing (FDC)
Intravenous Titration Test (IVRT)
Cell Line In-house Testing (ICR)
Pharmacokinetic Testing Segment by Application
Hospital
Clinic
Research Institutions
Pharmacokinetic Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacokinetic Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharmacokinetic Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacokinetic Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pharmacokinetic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Dissolution Testing (FDC)
- Intravenous Titration Test (IVRT)
- Cell Line In-house Testing (ICR)
Applications
- Hospital
- Clinic
- Research Institutions
Companies covered
- Certara, L.P.
- Evotec AG
- Pacific BioLabs
- GVK Biosciences Private Limited
- SGS SA
- LGC Limited
- Pharmaceutical Product Development, LLC
- Charles River Laboratories International, Inc.
- Creative Bioarray
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharmacokinetic Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Oral Dissolution Testing (FDC)
- 2.2.3 Intravenous Titration Test (IVRT)
- 2.2.4 Cell Line In-house Testing (ICR)
- 2.3 Pharmacokinetic Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Research Institutions
- 2.4 Assumptions and Limitations
3 Pharmacokinetic Testing Breakdown Data by Type
- 3.1 Global Pharmacokinetic Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Pharmacokinetic Testing Forecasted Market Size by Type (2027-2032)
4 Pharmacokinetic Testing Breakdown Data by Application
- 4.1 Global Pharmacokinetic Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Pharmacokinetic Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pharmacokinetic Testing Market Perspective (2021-2032)
- 5.2 Global Pharmacokinetic Testing Growth Trends by Region
- 5.2.1 Global Pharmacokinetic Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pharmacokinetic Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Pharmacokinetic Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Pharmacokinetic Testing Market Dynamics
- 5.3.1 Pharmacokinetic Testing Industry Trends
- 5.3.2 Pharmacokinetic Testing Market Drivers
- 5.3.3 Pharmacokinetic Testing Market Challenges
- 5.3.4 Pharmacokinetic Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pharmacokinetic Testing Players by Revenue
- 6.1.1 Global Top Pharmacokinetic Testing Players by Revenue (2021-2026)
- 6.1.2 Global Pharmacokinetic Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Pharmacokinetic Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pharmacokinetic Testing Head Office and Area Served
- 6.4 Global Pharmacokinetic Testing Players, Product Type & Application
- 6.5 Global Pharmacokinetic Testing Manufacturers Established Date
- 6.6 Global Pharmacokinetic Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pharmacokinetic Testing Market Size (2021-2032)
- 7.2 North America Pharmacokinetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pharmacokinetic Testing Market Size by Country (2021-2026)
- 7.4 North America Pharmacokinetic Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pharmacokinetic Testing Market Size (2021-2032)
- 8.2 Europe Pharmacokinetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pharmacokinetic Testing Market Size by Country (2021-2026)
- 8.4 Europe Pharmacokinetic Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pharmacokinetic Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Pharmacokinetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pharmacokinetic Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pharmacokinetic Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pharmacokinetic Testing Market Size (2021-2032)
- 10.2 South America Pharmacokinetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pharmacokinetic Testing Market Size by Country (2021-2026)
- 10.4 South America Pharmacokinetic Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pharmacokinetic Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Pharmacokinetic Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pharmacokinetic Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pharmacokinetic Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Certara, L.P.
- 12.1.1 Certara, L.P. Company Information
- 12.1.2 Certara, L.P. Business Overview
- 12.1.3 Certara, L.P. Revenue in Pharmacokinetic Testing Business (2021-2026)
- 12.1.4 Certara, L.P. Pharmacokinetic Testing Product Portfolio
- 12.1.5 Certara, L.P. Recent Developments
- 12.2 Evotec AG
- 12.2.1 Evotec AG Company Information
- 12.2.2 Evotec AG Business Overview
- 12.2.3 Evotec AG Revenue in Pharmacokinetic Testing Business (2021-2026)
- 12.2.4 Evotec AG Pharmacokinetic Testing Product Portfolio
- 12.2.5 Evotec AG Recent Developments
- 12.3 Pacific BioLabs
- 12.3.1 Pacific BioLabs Company Information
- 12.3.2 Pacific BioLabs Business Overview
- 12.3.3 Pacific BioLabs Revenue in Pharmacokinetic Testing Business (2021-2026)
- 12.3.4 Pacific BioLabs Pharmacokinetic Testing Product Portfolio
- 12.3.5 Pacific BioLabs Recent Developments
- 12.4 GVK Biosciences Private Limited
- 12.4.1 GVK Biosciences Private Limited Company Information
- 12.4.2 GVK Biosciences Private Limited Business Overview
- 12.4.3 GVK Biosciences Private Limited Revenue in Pharmacokinetic Testing Business (2021-2026)
- 12.4.4 GVK Biosciences Private Limited Pharmacokinetic Testing Product Portfolio
- 12.4.5 GVK Biosciences Private Limited Recent Developments
- 12.5 SGS SA
- 12.5.1 SGS SA Company Information
- 12.5.2 SGS SA Business Overview
- 12.5.3 SGS SA Revenue in Pharmacokinetic Testing Business (2021-2026)
- 12.5.4 SGS SA Pharmacokinetic Testing Product Portfolio
- 12.5.5 SGS SA Recent Developments
- 12.6 LGC Limited
- 12.6.1 LGC Limited Company Information
- 12.6.2 LGC Limited Business Overview
- 12.6.3 LGC Limited Revenue in Pharmacokinetic Testing Business (2021-2026)
- 12.6.4 LGC Limited Pharmacokinetic Testing Product Portfolio
- 12.6.5 LGC Limited Recent Developments
- 12.7 Pharmaceutical Product Development, LLC
- 12.7.1 Pharmaceutical Product Development, LLC Company Information
- 12.7.2 Pharmaceutical Product Development, LLC Business Overview
- 12.7.3 Pharmaceutical Product Development, LLC Revenue in Pharmacokinetic Testing Business (2021-2026)
- 12.7.4 Pharmaceutical Product Development, LLC Pharmacokinetic Testing Product Portfolio
- 12.7.5 Pharmaceutical Product Development, LLC Recent Developments
- 12.8 Charles River Laboratories International, Inc.
- 12.8.1 Charles River Laboratories International, Inc. Company Information
- 12.8.2 Charles River Laboratories International, Inc. Business Overview
- 12.8.3 Charles River Laboratories International, Inc. Revenue in Pharmacokinetic Testing Business (2021-2026)
- 12.8.4 Charles River Laboratories International, Inc. Pharmacokinetic Testing Product Portfolio
- 12.8.5 Charles River Laboratories International, Inc. Recent Developments
- 12.9 Creative Bioarray
- 12.9.1 Creative Bioarray Company Information
- 12.9.2 Creative Bioarray Business Overview
- 12.9.3 Creative Bioarray Revenue in Pharmacokinetic Testing Business (2021-2026)
- 12.9.4 Creative Bioarray Pharmacokinetic Testing Product Portfolio
- 12.9.5 Creative Bioarray Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst